RPRX

Royalty Pharma plc

Ten-year history of valuation, safety, growth and profitability, with percentile bands against RPRX’s own range.

Snapshot

P/E

347.0×

P48

Yield

1.6%

P49

FCF payout

13.4%

Net debt / EBITDA

46.20

P39

DGR 5y

7.3%

ROIC

0.8%

P27

Value

Is the share cheap or dear by its own history?

RPRX is mid-band on valuation. P/E at P48 (347.0x); yield at P49 (1.6%).

Safety

Can the business comfortably cover the dividend?

FCF payout sits at P5 (13%) of its history. Leverage (Net Debt/EBITDA) at P39 (46.20); interest cover at P37 (1.42).

Growth

Is the dividend and the cash behind it still growing?

5-year dividend growth at P0 (7%) of its 10y range. FCF growth P71 (24%); ROIC P27 (1%).

Partial data in this window.

Profitability

Is the engine getting better or worse at making money?

Gross margin at P0 (89%) of its history. Operating margin P37 (62%); net margin P24 (32%).

Forecast your income with the RPRX dividend calculator

Free account

Sign up free to look up 10 stocks a day.

Anonymous lookups are capped at three a day. A free account bumps that to ten, and your counter resets at midnight UK time.

Inspect surfaces history; it does not predict the future. Nothing here is financial advice or an instruction to buy or sell. Always do your own research. See the Terms of Service.